Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis.
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
G Protein-Coupled Receptors in Myelinating Glia.
Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats.
Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.
Physical activity and cognitive function in adults with multiple sclerosis: an integrative review.
Normonatremic osmotic demyelination in the setting of acquired immune deficiency syndrome and malnutrition: case report and literature review.
Transneuronal Degeneration of Thalamic Nuclei following Middle Cerebral Artery Occlusion in Rats.
Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply.
Constipation prevalence in multiple sclerosis about a cohort of 81 patients.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Corpus callosum microstructural changes associated with Kawashima Nintendo Brain Training in patients with multiple sclerosis.
Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.
Cluster headache: When to worry? Two case reports.
Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis.
Age-related morphological regression of myelinated fibers and capillary architecture of distal peripheral nerves in rats.
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
Proteolytic processing of Neuregulin-1.
Protective Effect of Low-Intensity Pulsed Ultrasound on Memory Impairment and Brain Damage in a Rat Model of Vascular Dementia.
Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease.
Pages
« first
‹ previous
…
821
822
823
824
825
826
827
828
829
…
next ›
last »